Citation Tools

Download PDFPDF
Pharmacological interventions
Vesicular monoamine transporter type 2 inhibition can lead to effective and tolerable management of tardive dyskinesia

Download to a citation manager

Cite this article as:
Citrome L
Vesicular monoamine transporter type 2 inhibition can lead to effective and tolerable management of tardive dyskinesia